Fortrea
Elizabeth Phillips currently serves as Associate Director for One Clinical Oncology Global Clinical Project Delivery at Fortrea, a position held since May 2023. Prior experience includes roles as Associate Director and Principal Clinical Team Lead at Labcorp Drug Development from February 2021 to May 2023, and Clinical Team Manager at PRA Health Sciences from April 2013 to May 2023, where responsibilities involved leading clinical trial activities, ensuring compliance with regulatory requirements, and mentoring junior staff. Earlier career positions include Protocol Monitor/Data Manager at The EMMES Corporation, Research Assistant at the George Washington University Biostatistics Center, and Safety and Pharmacovigilance Associate at Technical Resources International. Elizabeth holds a Master of Business Administration from The George Washington University and two Bachelor of Arts degrees from the University of Missouri-Columbia.
This person is not in any offices
Fortrea
11 followers
Fortrea (Nasdaq: FTRE) is a leading global provider of clinical development and patient access solutions to the life sciences industry. We partner with emerging and large biopharmaceutical, medical device and diagnostic companies to drive healthcare innovation that accelerates life changing therapies to patients in need. Fortrea provides phase I-IV clinical trial management, clinical pharmacology, differentiated technology-enabled trial solutions and post-approval services. Fortrea’s solutions leverage three decades of experience spanning more than 20 therapeutic areas, a passion for scientific rigor, exceptional insights and a strong investigator site network. Our talented and diverse team of approximately 19,000 people working in more than 90 countries is scaled to deliver focused and agile solutions to customers globally. Learn more about how Fortrea is becoming a transformative force from pipeline to patient at Fortrea.com.